# Trial of OnabotulinumtoxinA for Depression in Parkinson Disease

> **NCT03069911** · PHASE1 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 3 (actual)

## Conditions studied

- Parkinson Disease
- Depression

## Interventions

- **BIOLOGICAL:** OnabotulinumtoxinA
- **BIOLOGICAL:** Control

## Key facts

- **NCT ID:** NCT03069911
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-01
- **Primary completion:** 2019-05-30
- **Final completion:** 2019-06-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Unable to recruit required participants
- **Last updated:** 2019-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03069911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03069911, "Trial of OnabotulinumtoxinA for Depression in Parkinson Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03069911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*